InsidersTradesSigma
Track the 九强生物 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 九强生物 has logged 2 insider filings. Market capitalisation: €6.7bn. The latest transaction was filed on 29 August 2022 (Sale). Among the most active insiders: 罗爱平. The full history is free.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€4m
2 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,510 of 29,063 companies
55.6
score / 100
Value49
Quality62
FCF yld7.9%
Earn yld2.8%
EV/EBITDA21.7x
ROE5.2%
Gross mgn79%
Net mgn14%
Debt/EBITDA3.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 August 2022
Acerca de 九强生物
九强生物 es una empresa centrada en el sector de la salud y farmacéutico, especializada en el desarrollo de productos biológicos. Cotiza en el mercado XSHE.